IDEXX Laboratories, Inc. (IDXX) — Analyst outlook / Analyst consensus target is. Based on 22 analyst ratings, the consensus is bullish — 13 Buy, 8 Hold, 1 Sell.
The consensus price target is $784.38 (low: $730.00, high: $830.00), representing an upside of 34.3% from the current price $584.05.
Analysts estimate Earnings Per Share (EPS) of $10.46 and revenue of $3.88B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $10.77 vs est $10.46 (beat +3%). 2025: actual $13.17 vs est $12.93 (beat +1.9%). Analyst accuracy: 98%.
IDXX Stock — 12-Month Price Forecast
$784.38
▲ +34.30% Upside
Average Price Target
Based on 22 Wall Street analysts offering 12-month price targets for IDEXX Laboratories, Inc., the average price target is $784.38, with a high forecast of $830.00, and a low forecast of $730.00.
The average price target represents a +34.30% change from the last price of $584.05.
Highest Price Target
$830.00
Average Price Target
$784.38
Lowest Price Target
$730.00
IDXX Analyst Ratings
Buy
Based on 22 analysts giving stock ratings to IDEXX Laboratories, Inc. in the past 3 months
EPS Estimates — IDXX
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $10.77
vs Est $10.46
▲ 2.9% off
2025
Actual $13.17
vs Est $12.93
▲ 1.8% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — IDXX
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $3.898B
vs Est $3.879B
▲ 0.5% off
2025
Actual $4.304B
vs Est $4.285B
▲ 0.4% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
